This Government Contract opportunity from Department Of Defense was posted on January 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

GUARDIAN Industry Day

Closed

DARPA-SN-26-24Federal

Submission Closed01/22/2026, 04:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714

New

Federal

Infinium Global Diversity Array Kits.Illumina, Inc. is the sole manufacturer of the Infinium Global Diversity Array Kits and is the only provider capable of delivering specialized technical support for these arrays and associated reagents. In the event of assay failure, Illumina’s dedicated team of technical applications scientists and field application scientists, who possess deep expertise in the assay system, will troubleshoot issues and, when necessary, provide replacement reagents at no cost. This level of specialized, manufacturer-backed support is unmatched by any other provider and is critical to ensuring assay reliability and research continuity. The solicitation, numbered 75N98026Q00671, issued by the National Institutes of Health under the Department of Health and Human Services, seeks procurement of these kits with a response deadline of July 2, 2026, and is managed by the office located in Bethesda, Maryland.

National Institutes Of Health Olao

POSTED

DEADLINE

Bioinformatics Analysis & Data InterpretationThis contract solicits computational analysis of genomic data through bioinformatics pipelines, focusing on variant calling, annotation, and the generation of clinical reports. The work requires specialized expertise in processing large-scale genomic datasets to identify and interpret genetic variants with clinical relevance, ensuring accurate and actionable results. The project is structured as a subcontract under the NAICS code 541714, which corresponds to scientific research and development in the life sciences. The opportunity was posted on June 18, 2026, with a deadline for responses set for July 8, 2026. It is issued by the state of Utah, with no specified office address or point of contact details, and no set-aside classification is indicated. The performance location is not defined, and the opportunity is accessible via a public portal link hosted on Bonfire Hub.

POSTED

DEADLINE

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)The National Institutes of Health, through the Gabriella Miller Kids First Pediatric Research Program, is inviting applications to submit pediatric samples for advanced genomic and molecular analyses aimed at uncovering the genetic foundations of childhood cancers and congenital anomalies. Applicants are encouraged to propose sequencing of existing pediatric cohorts to investigate somatic and germline genetic contributions to these conditions, explore the molecular links between congenital anomalies and elevated cancer risk, or broaden the spectrum of pediatric disorders represented in the Kids First Data Resource. The program supports a wide range of technologies including whole genome, exome, and transcriptome sequencing, as well as clinical-grade sequencing, long-read sequencing, proteomics, and epigenomic assays on tumor or affected tissues, provided the scientific rationale is strong. There is a specific emphasis on expanding representation of populations already included in existing Kids First projects to enhance the diversity and utility of the data. All generated data, along with associated clinical and phenotypic information, will be deposited into the Kids First Data Resource Center, making it openly available to the broader research community to accelerate discoveries in pediatric health. This opportunity is issued under solicitation PAR-27-071, with a submission deadline of January 11, 2027, and is not open for clinical trials. Applications must be submitted through Grants.gov, and inquiries can be directed to the designated point of contact at the NIH. The initiative is part of a larger federal effort under the U.S. Department of Health and Human Services to advance pediatric research through open data sharing and cutting-edge genomic technologies.

National Institutes Of Health

POSTED

DEADLINE

Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)The Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) is a limited competition funding opportunity issued by the National Institutes of Health under PAR-27-055 to strengthen biomedical research capacity at institutions in states historically underserved by NIH funding. This initiative supports IDeA-eligible institutions in expanding their research infrastructure through COBRE-E, which focuses on growing the faculty base and establishing new research projects and core facilities in strategically important scientific areas, and sustaining these gains through COBRE-S, which aims to consolidate research cores and further develop institutional research excellence. Applications must demonstrate a clear pathway to long-term self-sufficiency and alignment with the institution’s research priorities, with clinical trials explicitly prohibited under this P30 award mechanism. The solicitation is open only to eligible organizations that have previously received COBRE funding and are positioned to advance to the expansion or sustainability phase. The opportunity is governed by standard NIH peer-review procedures, with funding decisions based solely on scientific merit. Applications must be submitted by the deadline of May 25, 2029, and institutions interested in applying should reference the official NIH Grants.gov page for detailed eligibility criteria and submission guidelines. Questions regarding the program can be directed to the designated NIH point of contact through email or phone.

National Institutes Of Health

POSTED

DEADLINE

GREGoRi Innovation Projects (U01 Clinical Trial Optional)The GREGoRi Innovation Projects initiative, funded by the National Institutes of Health under the Department of Health and Human Services, aims to revolutionize the diagnosis of rare genetic diseases by supporting highly innovative experimental and computational approaches that go beyond current methodologies. This funding opportunity encourages the development and rigorous testing of novel tools, molecular technologies, and analytical frameworks capable of identifying causal genes or variants in rare disorders with transformative speed and accuracy. The program seeks proposals that challenge existing paradigms in rare disease genomics, prioritizing groundbreaking ideas with the potential to significantly improve diagnostic outcomes and expand understanding of genetic mechanisms. Applicants must submit proposals by the deadline of October 30, 2026, through the solicitation number RFA-HG-27-013, which is structured as a U01 award with clinical trials being optional. The initiative is open to federal and non-federal entities without set-asides, and funding recipients are expected to operate across the United States with no specific geographic restrictions. All inquiries should be directed to the designated point of contact at nhgri-gregor@mail.nih.gov or by phone at 301-402-2541. Further details and the official application portal are accessible via the provided grants.gov link.

National Institutes Of Health

POSTED

5 days ago

DEADLINE

in 4 months

AI Contract Overview

The Defense Advanced Research Projects Agency's Biological Technologies Office is organizing an in-person and virtual Proposer’s Day for the GUARDIAN Program, aimed at engaging the potential proposer community ahead of a forthcoming Program Solicitation. This event will take place on January 27, 2026, from 8:30 AM to 1:30 PM Eastern Standard Time, and requires advance registration. The GUARDIAN Program focuses on the genetic utilization for advanced regulation and defense of indigenous and native species, reflecting DARPA's commitment to cutting-edge biological technologies. The solicitation, identified by DARPA-SN-26-24, was posted on December 24, 2025, with responses due by January 22, 2026, at 4:00 PM EST. The relevant NAICS code is 541714, indicating research and development in biotechnology. The contracting office is located in Arlington, VA, under the Department of Defense. Interested parties can reach out to Dr. Catherine Campbell at DARPA/BTO for more information. Additional details and registration can be accessed through the official SAM.gov website.

General Info

DARPA's GUARDIAN Program Proposer’s Day on January 27, 2026, requires advance registration.

Agency

Department Of Defense → Defense Advanced Research Projects AgcyView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Set-Aside

NONE

Documents

(5)

DARPA-SN-26-24 GUARDIAN Industry Day Special Notice

PDF•4 pages•special-notice

GUARDIAN_ID_ATT2_Lightning_Template.pptx

PPTX

DARPA-SN-26-24-Amendment-02.pdf

PDF

Guardian ID Teaming Profile Guidance

DOCX•1 page•teaming-profile

DARPA-SN-26-24 Amendment 01 - GUARDIAN Industry Day Clarification

PDF•5 pages•amendment

AI Contract Breakdown

Uniform Contract Format

Timeline

2 updates

PhaseClosed

Amendment 1Jan 12

Contract was updated

Response DeadlineJan 22

Deadline has passed

PostedJan 26

special-notice

Amendment 2Jan 26

Contract was updated

Submission Closed

01/22/2026, 04:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy

Contacts1 person available

OfficeARLINGTON, VA, 222032114, USA

Organization / Agency

Department Of Defense → Defense Advanced Research Projects Agcy

View Agency Profile

Office AddressARLINGTON, VA, 222032114, USA

Contacts

Dr. Catherine Campbell DARPA/BTO

contact@example.gov

Full Description

The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is hosting an in person and virtual Proposer’s Day for the potential proposer community in support of a planned Program Solicitation (PS) for the Genetic Utilization for Advanced Regulation and Defense of Indigenous and Native Species (GUARDIAN) Program. The Industry Day will be held on January 27th, 2026 from 8:30 AM to 1:30 PM (EST). Advance registration is required. Note: all times listed in this announcement and on the registration website are Eastern Standard Time.

NOTE: DRAFT Program Solicitation added on January 26, 2026.